183 related articles for article (PubMed ID: 23555990)
41. Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.
Ng WK; Yazan LS; Ismail M
Toxicol In Vitro; 2011 Oct; 25(7):1392-8. PubMed ID: 21609759
[TBL] [Abstract][Full Text] [Related]
42. Apoptotic activities of thymoquinone, an active ingredient of black seed (Nigella sativa), in cervical cancer cell lines.
Ichwan SJ; Al-Ani IM; Bilal HG; Suriyah WH; Taher M; Ikeda MA
Chin J Physiol; 2014 Oct; 57(5):249-55. PubMed ID: 25241984
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling.
Hussain AR; Uddin S; Ahmed M; Bu R; Ahmed SO; Abubaker J; Sultana M; Ajarim D; Al-Dayel F; Bavi PP; Al-Kuraya KS
J Pathol; 2010 Oct; 222(2):180-90. PubMed ID: 20632385
[TBL] [Abstract][Full Text] [Related]
44. Thymoquinone induces mitochondria-mediated apoptosis in acute lymphoblastic leukaemia in vitro.
Salim LZ; Mohan S; Othman R; Abdelwahab SI; Kamalidehghan B; Sheikh BY; Ibrahim MY
Molecules; 2013 Sep; 18(9):11219-40. PubMed ID: 24036512
[TBL] [Abstract][Full Text] [Related]
45. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
[TBL] [Abstract][Full Text] [Related]
46. Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis.
Badr G; Lefevre EA; Mohany M
PLoS One; 2011; 6(9):e23741. PubMed ID: 21912642
[TBL] [Abstract][Full Text] [Related]
47. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
[TBL] [Abstract][Full Text] [Related]
48. Thymoquinone, extract from Nigella sativa seeds, protects human skin keratinocytes against UVA-irradiated oxidative stress, inflammation and mitochondrial dysfunction.
Liang J; Lian L; Wang X; Li L
Mol Immunol; 2021 Jul; 135():21-27. PubMed ID: 33857815
[TBL] [Abstract][Full Text] [Related]
49. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.
Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA
Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738
[TBL] [Abstract][Full Text] [Related]
50. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570
[TBL] [Abstract][Full Text] [Related]
51. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS.
Woo CC; Hsu A; Kumar AP; Sethi G; Tan KH
PLoS One; 2013; 8(10):e75356. PubMed ID: 24098377
[TBL] [Abstract][Full Text] [Related]
52. A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma.
Habineza Ndikuyeze G; Gaurnier-Hausser A; Patel R; Baldwin AS; May MJ; Flood P; Krick E; Propert KJ; Mason NJ
PLoS One; 2014; 9(5):e95404. PubMed ID: 24798348
[TBL] [Abstract][Full Text] [Related]
53. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic implications and clinical manifestations of thymoquinone.
Alam M; Hasan GM; Ansari MM; Sharma R; Yadav DK; Hassan MI
Phytochemistry; 2022 Aug; 200():113213. PubMed ID: 35472482
[TBL] [Abstract][Full Text] [Related]
55. RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
Zhang M; Xu-Monette ZY; Li L; Manyam GC; Visco C; Tzankov A; Wang J; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Pham LV; Young KH
Aging (Albany NY); 2016 Dec; 8(12):3321-3340. PubMed ID: 27941215
[TBL] [Abstract][Full Text] [Related]
56. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.
Chen J; Xu-Monette ZY; Deng L; Shen Q; Manyam GC; Martinez-Lopez A; Zhang L; Montes-Moreno S; Visco C; Tzankov A; Yin L; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Pham L; Young KH
Oncotarget; 2015 Mar; 6(8):5597-614. PubMed ID: 25704881
[TBL] [Abstract][Full Text] [Related]
57. Cell-Penetrating Peptide Conjugated Au Nanoclusters Selectively Suppress Refractory Lymphoma Cells
Lai J; Yao Y; Zhang Y; Liu Y; Lu C; Meng C; Xia D; Li Y; Cao K; Gao X; Yuan Q
Bioconjug Chem; 2023 Jan; 34(1):228-237. PubMed ID: 36521093
[TBL] [Abstract][Full Text] [Related]
58. A multiple endpoint approach reveals potential in vitro anticancer properties of thymoquinone in human renal carcinoma cells.
Costa JG; Keser V; Jackson C; Saraiva N; Guerreiro Í; Almeida N; Camões SP; Manguinhas R; Castro M; Miranda JP; Fernandes AS; Oliveira NG
Food Chem Toxicol; 2020 Feb; 136():111076. PubMed ID: 31883990
[TBL] [Abstract][Full Text] [Related]
59. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
Ahn KS; Sethi G; Aggarwal BB
Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
[TBL] [Abstract][Full Text] [Related]
60. Thymoquinone induces apoptosis and increase ROS in ovarian cancer cell line.
Taha MM; Sheikh BY; Salim LZ; Mohan S; Khan A; Kamalidehghan B; Ahmadipour F; Abdelwahab SI
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):97-101. PubMed ID: 27262811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
